How to Source Sparsentan for Pharmaceutical Formulation
Sparsentan (Tablets, 200mg, 400mg) is classified under Nephrology. It is therapeutically aligned with reference brands such as Filspari (USA). This guide highlights key sourcing factors buyers should consider when procuring high-quality Sparsentan for formulation, R&D, or bulk manufacturing.
Product Overview:
Sparsentan is an oral dual endothelin type A receptor (ET_A) and angiotensin II type 1 receptor (AT_1) antagonist, designed to reduce proteinuria in adults with primary immunoglobulin A nephropathy (IgAN) who are at risk of rapid disease progression. It is marketed under the brand name Filspari and available in 200 mg and 400 mg tablets. Because of its novel mechanism and risk profile (including hepatotoxicity), it is subject to a restricted drug-distribution program.
Sparsentan API – ideal for compliant pharmaceutical formulation.
Quick Insight: Over 60% of formulation delays are linked to poor API sourcing. A well-planned sourcing strategy can reduce risk and accelerate market entry.
1. Regulatory Compliance & Documentation
Ensure suppliers provide:
- ✔ Valid DMF (Drug Master File)
- ✔ COA (Certificate of Analysis) for each batch
- ✔ GMP, ISO, or ICH Q7 compliance certificates
2. Purity, Grade & Specification Matching
Sparsentan must meet exact grade and purity for your dosage form:
- ✔ USP / EP / JP grade verification
- ✔ Particle size distribution check
- ✔ Residual solvent and heavy metal limits
3. Supplier Reliability & Audit History
- ✔ Positive past audit reports
- ✔ Pharma client references
- ✔ Years of proven API manufacturing experience
4. Commercial Terms: Pricing, MOQ & Flexibility
- ✔ Transparent pricing
- ✔ Pilot batch MOQ flexibility
- ✔ Volume-based discounts
5. Lead Time, Inventory & Logistics
Typical lead time for Sparsentan is 4–6 weeks.
- ✔ Emergency dispatch options
- ✔ Regional warehousing
- ✔ Special storage if needed
6. Formulation Support
- ✔ Technical datasheets
- ✔ Sample availability
- ✔ Stability study support
Pro Tip: Engage supplier formulation experts early — it can improve bioavailability and cut development time.
Conclusion
Sourcing Sparsentan is more than procurement—it’s a strategic partnership. With its tablets form and 200mg, 400mg specification, choosing a compliant supplier ensures consistent quality and regulatory approval. Prioritize documentation, verify compatibility, and build relationships with transparent, reliable suppliers to secure long-term success.
Frequently Asked Questions For Sourcing of Sparsentan
What is the typical lead time for Sparsentan?
Lead times range from 4–6 weeks depending on supplier and region.
Is Sparsentan available in multiple grades?
Yes — common grades include USP, EP, and JP. Verify grade suitability for your dosage form before purchase.
Does Sparsentan require special storage?
It should be stored in a cool, dry place away from direct sunlight.
Is a Drug Master File (DMF) available for Sparsentan?
Yes, a DMF is available for regulated markets upon request. It includes detailed quality, manufacturing, and stability data.
Can I request samples or a pilot batch of Sparsentan?
Yes — pilot batches or samples can be arranged for R&D, stability studies, or formulation trials. MOQ may vary based on region and regulatory scope.
What compliance certificates are available for Sparsentan?
Available documentation may include GMP, ISO 9001, ISO 14001, and ICH Q7 certificates, along with CoA, TDS, and stability data.
Is Sparsentan suitable for regulated markets like US/EU?
Yes — compliant with EU/US/WHO GMP standards and available with regulatory support documentation for filings.
Can Sparsentan be used in fixed-dose combinations?
Yes — many formulations support inclusion in FDCs. Compatibility studies and formulation consultation are available on request.
Subscribe to Our Newsletter
Stay updated on pharma trends and marketplace opportunities.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our
Privacy Policy.